NCT01267955 2026-04-13Vismodegib in Treating Patients With Advanced ChondrosarcomasNational Cancer Institute (NCI)Phase 2 Active not recruiting45 enrolled 10 charts
NCT06176989 2026-04-08Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting40 enrolled